MELISSA BAUER: Open Payments
NPI 1275976631 · SAGINAW, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$282 in 14 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $250 · 2025 $282
Food & beverage: $282
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $74 |
| Otsuka America Pharmaceutical, Inc. | 2 | $53 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $50 |
| AstraZeneca Pharmaceuticals LP | 1 | $20 |
| Inspire Medical Systems, Inc. | 1 | $20 |
| PFIZER INC. | 1 | $19 |
| Exact Sciences Corporation | 1 | $16 |
| GlaxoSmithKline, LLC. | 1 | $15 |
| Lilly USA, LLC | 1 | $15 |
Products named: REXULTI, Kerendia, Ozempic, BREZTRI, INSPIRE, ELIQUIS, Rybelsus, Cologuard Collection Kit.
Industry payments across MI — which companies pay providers there.
